Tribun Health
Private Company
Total funding raised: $30M
Overview
Tribun Health is a Paris-based leader in the digital pathology and AI diagnostics sector, offering a CE-marked and Health Canada-approved platform centered on its CaloPix® image management system. The company's integrated suite includes tools for macroscopic image capture (MacroCam), secure data storage (CaloPix® Archive), a growing catalog of AI applications for image analysis, and a telepathology module (TeleSlide® Patho). By enabling a fully digital diagnostic workflow and providing tools for pharmaceutical cohort building, Tribun Health is positioned at the intersection of clinical diagnostics and drug development, addressing critical needs in an era of increasing cancer cases and specialized care.
Technology Platform
Integrated digital pathology software platform centered on the CaloPix® image management system. The web-native, cloud-agnostic platform includes modules for macroscopic image capture (MacroCam), secure data storage/archive, a growing catalog of AI applications for image analysis, and telepathology (TeleSlide® Patho). It is designed for end-to-end digitization of pathology workflows.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Tribun Health competes in the digital pathology software and AI market against large, diversified players like Philips, Roche (Ventana), and Leica Biosystems, as well as specialized software companies like Proscia, Paige, and Indica Labs. Its differentiation lies in its agnostic, integrated platform approach, regulatory approvals, and dual focus on clinical and pharma customers.